HCA Healthcare (HCA) EVP granted 8,067 stock appreciation rights award

Rhea-AI Filing Summary

HCA Healthcare executive Michael R. McAlevey reported a new equity award. On January 29, 2026, he received 8,067 stock appreciation rights linked to HCA common stock, held as a direct beneficial owner.

The stock appreciation rights carry a $482.53 exercise price and vest in four equal annual installments beginning on January 29, 2027, giving this executive a long-term, performance-linked incentive tied to HCA Healthcare’s share price over time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McAlevey Michael R

Role EVP & Chief Legal & Admin Off.

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Right	8,067	$0.00	--

Holdings After Transaction: Stock Appreciation Right — 8,067 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAlevey Michael R

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Legal & Admin Off.

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$482.53	01/29/2026		A		8,067		01/29/2027(1)	01/29/2036	Common Stock	8,067	$0	8,067	D

Explanation of Responses:

1. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

	/s/ Kevin A. Ball, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HCA (HCA) report for Michael R. McAlevey?

HCA reported that EVP and Chief Legal & Administrative Officer Michael R. McAlevey received 8,067 stock appreciation rights on January 29, 2026. These rights are tied to HCA common stock and are held as a direct beneficial ownership position following the reported transaction.

What are the key terms of Michael R. McAlevey’s stock appreciation rights at HCA (HCA)?

The award consists of 8,067 stock appreciation rights with a $482.53 exercise price. They relate to HCA common stock and were granted on January 29, 2026, giving the executive potential value if HCA’s share price exceeds the exercise level over time.

How do Michael R. McAlevey’s HCA (HCA) stock appreciation rights vest over time?

The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. This means one-quarter of the 8,067 rights becomes exercisable each year, creating a staggered long-term incentive schedule aligned with multi-year service and performance at HCA Healthcare.

How many derivative securities does Michael R. McAlevey beneficially own at HCA (HCA) after this filing?

After the reported transaction, Michael R. McAlevey beneficially owns 8,067 derivative securities in the form of stock appreciation rights. These are recorded as directly owned, reflecting the full amount of the award granted on January 29, 2026, with vesting beginning in January 2027.

What type of security was granted to HCA (HCA) executive Michael R. McAlevey?

He was granted a derivative security described as a stock appreciation right. Each right is tied to HCA common stock, has a $482.53 exercise price, and becomes exercisable in stages over four years starting January 29, 2027, supporting long-term equity-based compensation.